-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Puma Biotechnology, Inc. quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from Q1 2024 to Q2 2025.
- Puma Biotechnology, Inc. Current Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $310K, a 18% decline year-over-year.
- Puma Biotechnology, Inc. annual Current Income Tax Expense (Benefit) for 2024 was $897K, a 17.2% decline from 2023.
- Puma Biotechnology, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $1.08M, a 138% increase from 2022.
- Puma Biotechnology, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $455K, a 40.4% increase from 2021.
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)